Keyphrases
Confidence Interval
100%
Initial Treatment
100%
Allogeneic Bone Marrow Transplantation
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
Alternative Donor
100%
Severe Aplastic Anemia
100%
Graft-versus-host Disease (GvHD)
75%
Overall Survival
50%
Immunosuppressive Therapy
50%
Bone Marrow Transplantation
50%
HLA-haploidentical
50%
Haploidentical Transplantation
50%
Consecutive Patients
25%
High Dose
25%
Follow-up Time
25%
Phase II Trial
25%
Fisher's Exact Test
25%
High Mortality
25%
Graft Failure
25%
Total Body Irradiation
25%
High Morbidity
25%
Cumulative Incidence
25%
Racial-ethnic Groups
25%
Reduced-intensity Conditioning
25%
Haploidentical Donor
25%
Matched Donors
25%
Failure-free Survival
25%
Marrow Failure
25%
Low-dose Irradiation
25%
GVHD Prophylaxis
25%
Medicine and Dentistry
Cyclophosphamide
100%
Bone Marrow Transplantation
100%
Aplastic Anemia
100%
Alternative Donor
100%
Graft Versus Host Reaction
80%
Immunosuppressive Treatment
40%
Whole Body Radiation
40%
Overall Survival
40%
Disease
20%
Drug Megadose
20%
Fisher Exact Test
20%
Graft Failure
20%
Low Drug Dose
20%
Ethnic Group
20%
Cumulative Incidence
20%
Reduced Intensity Conditioning
20%
Matched Donor
20%
Failure Free Survival
20%
Immunology and Microbiology
Cyclophosphamide
100%
Bone Marrow Transplantation
100%
Aplastic Anemia
100%
Graft-Versus-Host Disease
80%
Overall Survival
40%
Immunosuppressive Therapy
40%
Drug Megadose
20%
Low Drug Dose
20%
Conditioning
20%
Failure Free Survival
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Graft Versus Host Reaction
100%
Aplastic Anemia
100%
Overall Survival
50%
Immunosuppressive Agent
50%
Disease
25%
Graft Failure
25%
Failure Free Survival
25%
Agricultural and Biological Sciences
Cyclophosphamide
100%
Bone Marrow
100%
Confidence Interval
80%
Graft Versus Host Reaction
80%
Biochemistry, Genetics and Molecular Biology
Cyclophosphamide
100%
Overall Survival
66%
Drug Megadose
33%
Low Drug Dose
33%
Conditioning
33%
Failure Free Survival
33%